Medicaid expansion helps big business reduce competition.

Community Oncology Alliance Files Lawsuit Against Federal Government to Stop Unconstitutional Cut to Cancer Drug Reimbursement. Application of 2% Sequester Cut to Medicare Part B Drug Reimbursement is Unconstitutional and Illegal; Costing Seniors and Taxpayers Billions

Eighty-five percent of survey respondents said Trump’s drug pricing proposal could increase prescription drug costs and negatively impact patient care access.

We at New York Cancer & Blood Specialists would like to congratulate Dennis Caruana, who will soon enroll at Yale School of Medicine to become a doctor!

Putting Cancer Patients First and Lowering Drug is Critically Important, Community Oncology Supports Blueprint and is Working on Solutions

The Community Oncology Alliance (COA) has released the 2018 Community Oncology Practice Impact Report, which tracks data on the changing landscape of cancer care in the United States. It details a decade-long trend of closure and consolidation in the U.S. cancer system that has resulted in a dramatic shift of cancer care into the more expensive hospital setting. The report was released at the 2018 Community Oncology Conference.

COA Releases 2018 Practice Impact Report: 1,653 Clinics and/or Practices Closed, Acquired, Merged, or Struggling. COA Practice Impact Report Details Consolidation, Shift of U.S. Cancer Care System Into More Expensive Hospital Setting

Many large corporate hospitals have recently protested loudly that changes to an exploding Medicare program would force them to slash budgets, putting patient care at risk. In reality, it is the tremendous profit margins hospitals have been making from this program for the poor that has them most concerned. So why are some members of Congress so intent on stopping reform of this broken program?

Hospitals have been loudly protesting recent changes to an obscure Medicare program known as 340B drug discount program, saying that these changes put patient care at risk. The truth is, hospitals are most concerned with protecting their profit margins.

Patient Struggles With 340B Are Being Addressed